Exscientia acquires precision medicine company Allcyte for €50m

By NS Healthcare Staff Writer

17 Jun 21

Allcyte’s platform anticipates the activity of cancer treatments using AI to analyse the activity of drugs in live…

PharmaceuticalsDrug discovery

Exscientia enters into AI drug discovery partnership with Bristol Myers

By NS Healthcare Staff Writer

20 May 21

The collaboration will deploy AI to advance the discovery of small molecule therapeutic drug candidates in multiple therapeutic…

PharmaceuticalsDrug discovery

Swiss firm Roivant Sciences to go public in $7.3bn deal

By NS Healthcare Staff Writer

04 May 21

The transaction will enable Roivant Sciences to become a public entity and is expected to be listed on…

PharmaceuticalsDrug discovery

Exscientia receives up to $525m funding to expand AI drug discovery capabilities

By NS Healthcare Staff Writer

28 Apr 21

Exscientia intends to use the funding to advance its pipeline through clinical testing along with expanding its technology…

PharmaceuticalsDrug discovery

Exscientia secures $100m in funding round backed by BlackRock

By NS Healthcare Staff Writer

04 Mar 21

Exscientia intends to use proceeds from the financing round to further advance AI drug discovery platform and portfolio

PharmaceuticalsDrug discovery

Exscientia, University of Oxford to develop treatments for Alzheimer’s disease

By NS Healthcare Staff Writer

11 Feb 21

The collaboration will focus on a specific neuroinflammatory pathway associated with the development of AD

PharmaceuticalsDrug discovery

Boehringer Ingelheim to acquire NBE-Therapeutics for €1.18bn

By NS Healthcare Staff Writer

11 Dec 20

The acquisition will help expand Boehringer Ingelheim’s focus on patients with difficult-to-treat solid tumours

PharmaceuticalsDrug discovery

Exscientia gets Bill & Melinda Gates Foundation funding to discover new drugs

By NS Healthcare Staff Writer

10 Dec 20

Exscientia intends to use its AI-based Centaur platforms for genome scale AI-drug discovery and address critical global health…

PharmaceuticalsDrug discovery

Pfizer, PostEra partner to advance machine learning for drug discovery

By NS Healthcare Staff Writer

08 Dec 20

Pfizer will leverage its extensive data and expertise, while PostEra its technology capabilities to advance the preclinical drug…

PharmaceuticalsDrug discovery

Senhwa files multiple IND applications for CX-5461 to treat solid tumours

By NS Healthcare Staff Writer

27 Nov 20

CX-5461 works to stabilise DNA G-quadruplexes of cancer cells and facilitates disruption of the replication fork in cancer…

PharmaceuticalsDrug discovery